Microcrystalline Cellulose (MCC): A Comprehensive Primer and Selection Guide—Structural Features, Key Performance Metrics, and Application Scenarios
Microcrystalline Cellulose (MCC): A Comprehensive Primer and Selection Guide—Structural Features, Key Performance Metrics, and Application Scenarios
Microcrystalline cellulose (Microcrystalline Cellulose, MCC) is among the most commonly used—and arguably the most “basic yet critical”—cellulosic materials in both pharmaceutical formulation and materials science. It serves not only as a core excipient in oral solid dosage forms (tablets/capsules), but also as a widely used stabilizer, filler, and carrier in food, personal care, and research applications. Understanding MCC through the logic of “source → structure → performance → application” can significantly reduce trial-and-error in formulation design, experimental controls, and product selection.
What Is Microcrystalline Cellulose (MCC)?
According to authoritative definitions, MCC is a purified, partially depolymerized cellulose prepared from α-cellulose in plant fibrous pulp by mineral acid treatment (acid hydrolysis). A typical characteristic is a reduced degree of polymerization (often described as “typically < 400,” based on JECFA specifications). MCC is generally a white or off-white fine powder or granular powder; its flowability depends on particle size, particle morphology, and grade (some grades can exhibit relatively good flow).
- Common CAS No.: 9004-34-6.
- In the food additive system, MCC corresponds to INS / E-number: 460(i); JECFA also lists “cellulose gel” as a synonym.
- Note: In regulations/specifications, “cellulose gel” may be used as a synonym for MCC. However, in industrial formulation contexts, “colloidal MCC / cellulose gel” often specifically refers to an MCC + NaCMC co-processed system used to form a thixotropic suspension structure.
Why Do We “Need” MCC? — What Problems Does It Solve?
- Although natural cellulose (e.g., cotton fiber, wood pulp fiber) is abundant, it typically has long fibers, a dense structure, and significant batch-to-batch variability. When used directly in formulations, it often causes issues such as poor flow, unstable tabletability/compressibility, and poor blend uniformity.
- The value of MCC lies in controlled acid hydrolysis, which weakens/removes the more hydrolysis-prone amorphous regions of cellulose to obtain a more “ordered” microcrystalline structure, and further forms dried porous particles, thereby markedly improving its processability as a powder.
- For pharmaceutical formulations, MCC’s core value is direct-compression dry binding and compressibility. It may also contribute to disintegration (via wicking/capillary action) and powder flow, but the extent varies significantly with particle-size grade, lubrication system, and whether it is co-processed.
Structure and Microstructural Features: Why MCC Works So Well
Structural/Microstructural Feature (What) | Immediate Property (So what) | Resulting Performance / Application Effect (Now what) |
Purified, partially depolymerized cellulose (from α-cellulose via mineral acid treatment); typically lower DP | Shorter chains, better powder processability, more controllable batch consistency | A standardized base excipient for pharmaceutical/food grades (commonly used for direct compression/dilution/stabilization) |
High proportion of “microcrystalline domains” (more ordered than native cellulose) | More stable crystalline structural characteristics; suitable as a model substrate for cellulose studies | Used in research as a reference for cellulose structure/enzymatic hydrolysis/pretreatment; reduces experimental noise from material variability |
Porous particles / engineered particulate morphology | Larger true contact area during compaction; more favorable plastic deformation; stronger interparticle interactions | Strong direct-compression dry binding; easier to achieve higher tablet hardness (MCC is a classic direct-compression excipient) |
Hydroxyl-rich surface (–OH), readily forms hydrogen-bonding networks | One source of interparticle adhesion and strength | Improved tablet strength and cohesion; mechanism often explained using “hydrogen-bond networks” |
Practically insoluble in water and many organic solvents (MCC is insoluble in water, ethanol, ether, and dilute mineral acids; in sodium hydroxide solution it may show slight dissolution/swelling.) | Behaves more as dispersed/suspended particles than as a dissolved thickener | Formulation should be designed as a “powder dispersion system”: suspension stability often requires colloidal systems or co-processing approaches |
Particle size distribution can be defined/controlled (clear differences among grades) | Affects flow, blend uniformity, compressibility, and disintegration tendency | Selection strategy can be “flow-priority” vs. “compaction/adsorption-priority” by choosing particle-size grades |
Can be used for anti-caking/dispersion/stabilization (food additive functional description) | Improves powder behavior and helps stabilize systems | Used in food/personal care for anti-caking, dispersion, and stabilization functions |
Common Key Applications of MCC
Application Module | Typical Application Scenarios | Common Objectives / Value | Parameters / Forms to Prioritize During Selection |
Pharmaceutical solid dosage forms (core) | Diluent/filler; dry binder/direct compression; cores/pellets/spherical carriers; coating/controlled-release systems | Improve compressibility and tablet strength; improve flow and process window; carriers for multiparticulates/coating; controlled release or site-specific release | Particle size/PSD; moisture/LOD; bulk density/flow; co-processed or not (silicified / with CMC-Na); cores/spheres (Spheres) |
Food | Bulking/dietary fiber; stabilization/dispersion; anti-caking; texture and mouthfeel modification | Increase volume and fiber attributes; improve system stability and dispersion uniformity; reduce caking/bridging; optimize texture and processing stability | Regulatory designation (E 460(i)/(ii), FCC, etc.); particle size; hygroscopicity/moisture; dispersibility (whether colloidal system) |
Personal care / cosmetics | Suspension stability/thixotropic structure building (prefer colloidal/co-processed MCC such as MCC+CMC-Na); sensory/skin feel improvement; oil control/adsorptive carrier (single MCC commonly used) | Control viscosity and thixotropy; reduce sedimentation/phase separation; improve sensory feel; adsorption and fragrance/oil carrying | Whether colloidal/co-processed (determines structuring and thixotropy); particle size; porosity/adsorption; whether colloidal/co-processed (more conducive to forming stable structures) |
Research materials | Model substrate (cellulase hydrolysis/pretreatment); adsorption/carrier; composite filler; surface modification studies | Provide a reproducible cellulose model; a modifiable porous carrier; reinforce/fill composites; study interfaces and structure–property relationships | Batch consistency; particle size and specific surface area; moisture; purity/ash; surface chemistry (whether further modification is needed) |
Key Performance Indicators of MCC: What to Check for Selection and QC
Key Indicator | Why It Matters | Typical Direction of Impact (Engineering Meaning) | Selection Notes |
Particle size / particle size distribution (PSD) | Flow, blend uniformity, tableting performance, disintegration, surface adsorption | Finer: ↑ specific surface area, easier compaction but potentially poorer flow; coarser: better flow but may reduce compaction/tabletability | Direct compression requires balancing “flow + compressibility”; carriers/coating cores may favor more regular particles; stronger adsorption/dispersion may favor fine powder |
Moisture / Loss on drying (LOD) | Sticking/picking risk during compression, powder flow, compatibility with moisture-sensitive APIs, storage stability | Higher moisture: may increase sticking/caking; lower moisture: better for moisture-sensitive systems but may affect some compression windows | For moisture-sensitive APIs / water-controlled systems, prioritize low-moisture grades; if process issues occur (sticking, surface defects), check moisture first |
Bulk density / tapped density | Filling consistency, tablet weight variability, blend volume, manufacturability at scale | Higher density: better filling efficiency and smaller volume; lower density: larger volume at the same mass | Capsule filling or volume-limited formulations may prefer higher density; if weight variation is large, optimize density together with flow |
Compressibility / plastic deformation (compaction behavior) | Tablet strength in direct compression, hardness and friability, compaction process window | Stronger plastic deformation: better dry binding and higher tablet strength | For “direct compression / low-pressure compaction,” prioritize grades with stronger compaction performance; when compression force is limited, MCC is often the first-choice direct-compression backbone |
Porosity / specific surface area | Adsorption, wetting/capillary action, carrier capacity, dispersion and disintegration contribution | More porosity: stronger adsorption/wetting but may increase moisture uptake | For fragrance/oily component carriers or when stronger adsorption is needed, focus on porosity; for moisture-sensitive systems, balance against hygroscopicity |
Degree of polymerization / “partial depolymerization” | Defines MCC identity and batch consistency | MCC is described in authoritative specs as “partially depolymerized cellulose,” with DP typically below a certain level | For regulatory/pharmacopoeial compliance or reproducible research, prioritize grades explicitly meeting pharmacopeial/regulatory requirements; JECFA describes “DP typically < 400” |
Solubility / swelling | Determines whether it dissolves or only disperses | Typically “practically insoluble,” existing mainly as dispersed/suspended particles; may show slight swelling under certain alkaline conditions | In aqueous systems, do not treat it as a “soluble thickener”; for stable suspensions, focus on “colloidal/co-processed systems” |
Ash / inorganic impurities / heavy metals | Affects pharma/food compliance and sensitive systems (catalysis/optics/electrochemistry, etc.) | Higher impurities may introduce background interference or stability risks | For high-demand research (analytical, electrical properties) or regulated products, choose grades with clear limits/pharmacopoeial compliance |
pH (dispersion/extract) | Affects API stability, compatibility, and stability of certain colloidal systems | Deviations may affect stability or trigger interactions | For pH-sensitive systems (acid-/base-sensitive APIs or protein systems), consider pH as a release/benchmark parameter |
Co-processed/blended or not (silicified, MCC+CMC-Na, etc.) | Directly determines flow enhancement or suspension stability/thixotropic structuring | Silicified/SiO₂-containing systems often improve flow; MCC+CMC-Na co-processing favors stable dispersion/structure building | Poor flow / difficult direct compression: prefer silicified/flow-enhancing types; aqueous stability/thixotropy: prefer MCC+CMC-Na co-processed/colloidal systems |
Regulatory/pharmacopoeial designation (JP/Ph.Eur/NF/FCC/E 460(i)/(ii), etc.) | Determines compliance boundary, permitted uses, and quality system | Same-name products may differ greatly by grade (PSD/density/moisture/impurity limits/test methods) | Early R&D may screen trends with research grade, but before finalization 반드시 switch to the target regulatory grade and perform equivalence verification |
What Can MCC Do in Research and Experiments?
Beyond being studied as an excipient material itself, MCC also plays several highly practical roles in laboratories:
1. Model substrate for cellulase/cellulose degradation studies
- Many papers and experimental setups use Avicel (MCC) as a high-crystallinity cellulose substrate to study how pretreatment affects enzymatic hydrolysis kinetics.
2. Substrate for enzyme activity assays (especially for evaluating hydrolysis of insoluble cellulose)
- For example, some commercial methods use “Azo-Avicel” (dyed MCC) as a potential assay substrate for endo-cellulase and related enzymes, noting that MCC, due to its higher crystallinity, is typically more resistant to hydrolysis.
3. Carrier/adsorbent material and reference standard
- MCC is porous and hydroxyl-rich, and is often used in adsorption, dispersion, composite filling, and surface-modification studies as a reference material (particularly suitable for teaching and methodological validation).
Process / Pain Point → Recommended MCC Type
Process / Use Scenario | Common Pain Points | Recommended MCC Direction | Notes (How to judge whether you selected correctly) |
Direct compression (DC) | Insufficient powder compressibility, inadequate tablet hardness, narrow process window | Pharmacopoeial/regulatory MCC (for direct compression) → (if flow is poor) silicified/flow-enhancing co-processed MCC | MCC is widely used in direct compression; the core value is “strong dry binding and direct-compression tabletability.” |
Compression after wet granulation | Unstable granule formation; difficult balance between tablet strength and disintegration | MCC as diluent/backbone + (as needed) disintegrant combination | MCC acts as a backbone/base excipient; performance is balanced through disintegrants/lubricants |
Dry granulation/roller compaction | Post-compaction granule strength and compressibility; fines recycle | Focus on MCC grades with more stable “particle size/density/flow,” or flow-aid co-processed systems | Key metrics: density, PSD, and flow; avoid batch variability causing roller-compaction instability |
Coating cores/multiparticulate systems | Need regular spherical carriers, uniform coating, stable drug-layer deposition | Spherical/pellet MCC carriers (spheres/pellets) | Key criteria: sphericity, particle-size range, bulk density, and abrasion resistance |
Suspensions/colloidal systems (food/oral liquids/personal care) | Fast sedimentation, phase separation, insufficient thixotropy | Colloidal MCC or MCC+CMC-Na co-processed systems | Single MCC powder is often a “dispersion,” whereas colloidal/co-processed systems are better at building stable structural networks |
Powder flow aid/anti-caking demand | Poor flow, bridging, unstable feeding/discharge | Silicified / colloidal silica co-processed MCC, or additional flow aids | Goal: improve flow and anti-caking; JECFA also lists anti-caking/dispersion functions |
Research: cellulase hydrolysis/pretreatment | Need a stable “high-crystallinity cellulose model substrate” | MCC (as model substrate) | MCC is often used as a model insoluble cellulose substrate for pretreatment/hydrolysis kinetics comparisons (pay attention to batch consistency) |
Research: composites/surface modification | Difficult dispersion, poor interfacial compatibility | Choose MCC with particle size/surface properties better matched to the system; perform surface modification if necessary | Focus on particle size, specific surface area, moisture, and dispersion strategy; avoid applying “pharma direct-compression logic” directly to materials systems |
Use Notes and Safety Considerations
- Hygroscopicity and storage: MCC is stable but somewhat hygroscopic; store sealed in a cool, dry place.
- Incompatibilities: Incompatible with strong oxidizers; avoid strongly oxidative environments in experiments or formulations.
- Dust control: As a fine powder, implement dust control during weighing/transfer (mask/local exhaust) to avoid inhalation irritation and cross-contamination (especially in pharmaceutical systems). Fine powders can present combustible dust and dust explosion risks under certain conditions (especially during large-scale conveying, sieving, mixing, and dust collection systems). This is a common omission when scaling up from lab to production.
Aladdin Microcrystalline Cellulose (MCC) and Related Excipients/Materials—Selection Summary Table
The table below summarizes products on the Aladdin platform closely related to microcrystalline cellulose (MCC), including: core pharmaceutical/regulatory-grade MCC, co-processed/modified MCC systems (e.g., silicified, MCC+CMC-Na co-processed), cores/spherical carriers, powdered cellulose and particle-size series, as well as commonly co-used disintegrants, diluents, and glidants in oral solid dosage development, and selected coating polymers and materials-grade cellulose derivatives. This enables comparative selection based on process (direct compression/granulation/coating/cores) and target properties (flowability, compressibility, disintegration, controlled release/enteric performance, etc.).
Category | CAS No. | Aladdin Cat. No. | Product Name | Specification or Purity | Function / Application Notes |
Core MCC, pharmaceutical/regulatory grade | 9004-34-6 | Microcrystalline Cellulose | ChP, JP, European Pharmacopoeia (Ph.Eur), E 460(i), FCC, NF | Core diluent and structural backbone commonly used for direct compression/granulation; improves compressibility, tablet strength, and process stability | |
Core MCC, pharmaceutical/regulatory grade | 9004-34-6 | Microcrystalline Cellulose | JP, European Pharmacopoeia (Ph.Eur), E 460(i), FCC, NF | Same as above: pharmacopoeial/regulatory-grade MCC suitable for comparative selection in oral solid dosage forms | |
Core MCC, pharmaceutical/regulatory grade | 9004-34-6 | GMP1491563 | Tableting Aid K (Cellulose Powder) | GMP, PharmPure™, JP, BP, European Pharmacopoeia (Ph.Eur), NF | Dedicated excipient system for direct compression; improves flow/compressibility and widens the compaction process window |
Co-processed/modified MCC system | 9004-34-6 | Silicified Microcrystalline Cellulose | JP, European Pharmacopoeia (Ph.Eur), Colloidal anhydrous, E 460(i) and Silica, E 551, NF | SMCC concept: commonly used to improve powder flow, anti-caking, and compaction performance (more direct-compression friendly) | |
Co-processed/modified MCC system | - | Microcrystalline Cellulose and Sodium Carboxymethyl Cellulose | European Pharmacopoeia (Ph.Eur), E 460(i), E 466, NF | MCC+CMC-Na blend/co-processed: improves dispersion, stability, and processability (for suspension stability/process improvement, etc.) | |
Co-processed/modified MCC system | 9004-34-6 | Cellulose | Colloidal, microcrystalline, containing 10.0–20.0% sodium carboxymethyl cellulose as stabilizer | Colloidal MCC system: for suspension stabilization, thickening, and thixotropic structure building (typical aqueous systems) | |
Co-processed/modified MCC system | - | Co-processed Microcrystalline Cellulose–Sodium Carboxymethyl Cellulose | - | MCC+CMC-Na co-processed: commonly used to improve system stability and processability (confirm positioning via COA/instructions) | |
Co-processed/modified MCC system | - | Co-processed Microcrystalline Cellulose–Colloidal Silica | - | MCC+colloidal silica co-processed: improves flow/anti-caking and compaction stability | |
Cores/spherical carriers | 9004-34-6 | Microcrystalline Cellulose | JP, European Pharmacopoeia (Ph.Eur), NF, Spheres | Spherical carrier (cores/spherical particles): for coating cores, drug layering, and controlled-release carrier systems | |
Cores/spherical carriers | - | Microcrystalline Cellulose Cores | - | Core carriers for coating/layering/pelletization, etc. | |
Cellulose powder / powdered cellulose (MCC-related) | 9004-34-6 | Powdered Cellulose | JP, European Pharmacopoeia (Ph.Eur), E 460(ii), FCC, NF | Filling/dilution and bulking; similar functions to MCC; often used as a control or alternative/combined option | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | ≤25 μm | Finer particle size: larger surface area and stronger adsorption; for formulation/process screening and performance comparison | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | Particle size: 50 μm | Particle size affects flow, blend uniformity, and tableting; for matching different process windows | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | Particle size: 65 μm | Same as above: for balancing powder flow/tableting/carrier performance | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | Particle size: 90 μm | Relatively more favorable for flow; often used when more stable feeding/flow is needed | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | Particle size: 180 μm | More oriented toward carrier/high-flow needs; also for particulate structure studies | |
Cellulose powder / powdered cellulose (particle-size series) | 9004-34-6 | Cellulose Powder | Particle size: 250 μm | Same as above: coarser particles, often used for carriers/flow-priority selection | |
Cellulose powder / microcrystalline powder (research/material grade) | 9004-34-6 | Cellulose | Microcrystalline, powder, 20 μm | Microcrystalline powder for research/material uses; for blending, adsorption, dispersion, material modification, etc. | |
Cellulose powder / microcrystalline powder (research/material grade) | 9004-34-6 | Cellulose | Microcrystalline powder | Same as above: general-purpose microcrystalline powder for research/material applications | |
Disintegrant (frequently co-used) | 74811-65-7 | Croscarmellose Sodium | JP, European Pharmacopoeia (Ph.Eur), NF | Superdisintegrant: promotes disintegration via swelling and capillary action; commonly combined with MCC | |
Disintegrant (frequently co-used) | 9063-38-1 | Sodium Starch Glycolate (CMS) | AR | Superdisintegrant: accelerates disintegration and drug release (common in formulations) | |
Disintegrant (frequently co-used) | 25249-54-1 | Crospovidone (PVP-P) | USP, JP, European Pharmacopoeia (Ph.Eur), E 1202, NF | Superdisintegrant: primarily wicking/capillary absorption; commonly used in direct compression/granulation formulations | |
Binder/disintegration (common pharma excipient) | 9005-25-8 | P1373823 | Pregelatinized Starch | PharmPure™, pharmaceutical grade | Dual function binder/disintegrant: binder for wet granulation; aids binding and disintegration control in direct compression |
Filler/diluent (often compared/combined with MCC) | 10039-26-6 | L462903 | Lactose Monohydrate | GMP, PharmPure™, ChP, JP, BP, European Pharmacopoeia (Ph.Eur), NF, pharmaceutical grade, special “milkshake” tableting grade | Direct-compression/special grade diluent; often compared with MCC for process and taste/hardness performance |
Filler/diluent (often compared/combined with MCC) | 63-42-3 | Lactose, Anhydrous | AR, ≥98% | Common diluent; often used as a formulation control or in combination with MCC | |
Filler/diluent (often compared/combined with MCC) | 69-65-8 | Mannitol | AR, ≥98% | Taste-friendly/low-hygroscopic diluent; often screened with MCC for ODT/chewable tablets | |
Filler/diluent (often compared/combined with MCC) | 7789-77-7 | Dicalcium Phosphate Dihydrate | AR, ≥99% | Inorganic diluent; good flow and tablet hardness; often compared or combined with MCC | |
Glidant/anti-caking/adsorbent | 7631-86-9 | S433695 | Silicon Dioxide | ≥99% | Glidant, anti-caking, adsorbent; commonly used to optimize powder flow (also aligned with co-processing concepts) |
Cellulose derivative (thickening/binding/stabilizing) | 9004-32-4 | Carboxymethyl Cellulose | 800–1000 mPa·s | Thickening, stabilizing, binding, and suspending; rheology and stability adjustment in formulations | |
Cellulose derivative (thickening/stabilizing) | 9050-04-8 | Calcium Carboxymethyl Cellulose | - | Can be used for disintegration/stabilization/thickening (depending on grade/system); common alternative functional cellulose excipient | |
Cellulose ether (thickening/binding/film-forming) | 9004-65-3 | Hydroxypropyl Methylcellulose (HPMC) | 2% viscosity: 6 mPa·s; methoxy: 28–30%; hydroxypropoxy: 7.0–12% | Common coating/binding/controlled-release matrix material; also for thickening/stabilizing and processability improvement | |
Cellulose ether (thickening/binding/film-forming) | 9004-64-2 | Hydroxypropyl Cellulose (HPC) | 1,000–4,000 mPa·s; 2% aqueous solution at 20℃ | Binder/thickener/film former; for tablet binding, film coating, and rheology control | |
Cellulose ether (thickening/rheology) | 9004-62-0 | Hydroxyethyl Cellulose (HEC) | 100–200 mPa·s, 25℃ | Aqueous thickening and suspension stabilization (commonly for water-based systems) | |
Cellulose ether (thickening/film-forming) | 9004-67-5 | Methyl Cellulose (MC) | 100000 mPa·s | Thickening and film-forming (with thermal gelation); for rheology and film-forming applications | |
Controlled release/coating (hydrophobic film-former) | 9004-57-3 | Ethyl Cellulose (EC) | 180–220 mPa·s | Hydrophobic insoluble film former; sustained/controlled-release coating, sealing coat, taste masking/moisture barrier | |
Enteric coating polymer (key) | 9050-31-1 | H684408 | Hydroxypropyl Methylcellulose Phthalate | 31 wt.% phthalyl | Classic enteric coating material; protects acid-sensitive actives and enables intestinal release |
Enteric/solubilizing polymer (coating/ASD) | 71138-97-1 | Hydroxypropylmethyl Cellulose Acetate Succinate (Mw: 20–100k Da) | - | Enteric coating; also commonly used as an amorphous solid dispersion (ASD) carrier to improve dissolution and stability of poorly soluble drugs | |
Enteric coating polymer (classic) | 9004-38-0 | Cellulose Acetate Phthalate | - | Classic enteric coating material; for enteric formulations and site-specific release control | |
Cellulose ester / film material (materials-related) | 9004-35-7 | Cellulose Acetate | Average Mn by GPC ~30000 | Film-forming polymer; for membranes/coatings/fibers and materials modification research | |
Cellulose ester / film material (materials-related) | 9004-36-8 | Cellulose Acetate Butyrate | 35–39% | Film-forming and coating resin; for coatings/inks/plastics modification and related materials applications | |
Cellulose ester / film material (materials-related) | 9004-39-1 | Cellulose Acetate Propionate | Acetyl content ≤1%; propionyl content 42.5% | Film-forming and coating resin; for coatings, plastics, and films | |
Cellulose ester / film material (materials-related) | 9012-09-3 | Cellulose Triacetate | - | High film-forming cellulose ester; for films/fibers/separation membranes/optical film applications | |
Functional cellulose derivative (materials-related) | 9004-41-5 | Cyanoethyl Cellulose (CEC) | Degree of substitution: 2.6 mol cyanoethyl / 1 mol cellulose | Polarity-enhanced derivative; functional films/coatings, binders, electrolyte-related materials research | |
Chromatographic separation medium (bioseparation) | 9013-34-7 | Diethylaminoethyl Cellulose | 40–160 μm | Weak anion-exchange cellulose; for protein/nucleic acid separation and purification | |
Chromatographic separation medium (bioseparation) | 9000-11-7 | Carboxymethyl Cellulose CM-32 | - | Cation-exchange cellulose (CM type); for protein/peptide separation and purification |
Aladdin: https://www.aladdinsci.com/
